Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
2.
Ulus Travma Acil Cerrahi Derg ; 30(6): 415-422, 2024 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-38863294

RESUMEN

BACKGROUND: Effective pain management is vital in critical care settings, particularly post-surgery. Clinicians should maintain objective and efficient standards to assess pain in a patient-centered manner, in order to effectively manage this complex issue. A newer technology, the nociception level (NOL) index, shows promise in achieving this task through its multi-parameter evaluation. METHODS: This study was a prospective, controlled, randomized trial involving two groups of patients (n=30 each) in a diverse intensive care unit. Participants were over 18 years old with American Society of Anesthesiology scores ranging from I to III and were scheduled for critical care follow-up after general anesthesia. All subjects followed a standard analgesia protocol that included rescue analgesia. Drug administration was guided by a numeric rating scale and the critical care pain observation tool in the Control Group, while it was guided by nociception level index monitoring in the NOL Group. RESULTS: Pain scores between the two groups did not significantly differ. However, within the NOL Group, pain scores and noci-ception values displayed a strong positive correlation. Notably, total analgesic consumption was significantly lower in the NOL Group (p=0.036). CONCLUSION: Monitoring pain using the nociception level index is an effective method for detecting pain compared to standard pain scores utilized in critical care. Its guidance facilitates personalized analgesic titration. Additionally, the potential of nociception level index guidance to reduce the duration of intensive care and hospital stays may be linked to its effects on delirium, a connection that awaits further exploration in future studies.


Asunto(s)
Cuidados Críticos , Nocicepción , Dimensión del Dolor , Humanos , Método Doble Ciego , Masculino , Femenino , Dimensión del Dolor/métodos , Estudios Prospectivos , Persona de Mediana Edad , Cuidados Críticos/métodos , Adulto , Manejo del Dolor/métodos , Pronóstico , Unidades de Cuidados Intensivos , Anciano , Dolor Postoperatorio/tratamiento farmacológico , Dolor Postoperatorio/diagnóstico , Analgésicos/uso terapéutico , Analgésicos/administración & dosificación
3.
Urolithiasis ; 52(1): 20, 2024 Jan 06.
Artículo en Inglés | MEDLINE | ID: mdl-38183497

RESUMEN

Tranexamic acid, once a randomly used antifibrinolytic agent, has been in standard protocols for many specific surgeries. Studies are still needed to standardize the dose and route of tranexamic acid administration, examine its possible contributions in urological surgery, and establish a protocol for its use. To contribute to this goal, we designed a prospective, randomized, double-blind study on 75 patients with 1 control and 2 study groups (n = 25) who underwent percutaneous nephrolithotomy. Group Tranexamic acid received 10 mg/kg intravenous tranexamic acid preoperatively. And Group Irrigation received the same amount in the initial irrigation fluid. Primarily, we observed the total amount of blood transfusion and the changes in hemoglobin and hematocrit values during 2 postoperative days. Distinctively, we intraoperatively monitored hemoglobin continuously as a saturation hemoglobin value to assess the timing of the effect of tranexamic acid. Secondarily, we questioned surgical visual clarity with a standard visual score to reveal its contribution to surgical practicality, operative time, and residual fragment quantity. Our results revealed a significant difference in the reduction of hemoglobin and hematocrit change and blood transfusion in both tranexamic acid groups concerning control, especially on the second day (p = 0.003, p = 0.002, p = 0.001). Likewise, surgical visual scores were significantly better in both tranexamic acid groups (p = 0.018). In conclusion, intravenous or local administration of tranexamic acid at a dose of 10 mg/kg will be sufficient to maintain perioperative stability in hemoglobin values, use fewer blood products and provide a better visual advantage for the surgeon intraoperatively.The trial registration number is NCT05947435, and the date of registration is 07/07/2023, retrospectively registered.


Asunto(s)
Nefrolitotomía Percutánea , Ácido Tranexámico , Humanos , Ácido Tranexámico/uso terapéutico , Método Doble Ciego , Nefrolitotomía Percutánea/efectos adversos , Estudios Prospectivos , Hemorragia , Hemoglobinas
4.
Minerva Anestesiol ; 90(1-2): 22-30, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-37997303

RESUMEN

BACKGROUND: This study aims to reveal the perioperative analgesic efficacy of a new technique, anterior capsular shoulder block, in treating pain after shoulder arthroscopy compared to the interscalene brachial plexus block. METHODS: The study design is randomized, prospective, interventional, standardized and double-blind in the setting of orthopedic operating room and orthopedic postoperative ward. Forty patients between 18-90 years of age and with American Society of Anesthesiologists Physical Status classification I to III who received arthroscopic cuff repair surgery were randomized into two (1:1 distribution; N.=20) groups. The interventions were interscalene brachial plexus block for Group A and shoulder anterior capsular block for Group B. Primary measurements were pain scores within 48 hours. Secondarily total analgesia requirement, intraoperative heart rate and blood pressure, arthroscopic image quality were evaluated. RESULTS: Pain scores within postoperative 48 hours were similar between SHAC and ISB groups with no significant difference (P>0.05). Total analgesia requirement, intraoperative and postoperative rescue analgesia, was also similar with no significance (P>0.05). CONCLUSIONS: This study demonstrated that the anterior capsular shoulder block is an effective alternative with similar results to the interscalene brachial plexus block for managing pain after shoulder arthroscopy.


Asunto(s)
Bloqueo del Plexo Braquial , Hombro , Humanos , Anestésicos Locales , Artroscopía , Bloqueo del Plexo Braquial/métodos , Dolor Postoperatorio/tratamiento farmacológico , Dolor Postoperatorio/prevención & control , Estudios Prospectivos , Método Doble Ciego
6.
Ulus Travma Acil Cerrahi Derg ; 29(4): 458-462, 2023 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-36995199

RESUMEN

BACKGROUND: This study explored the change of anesthesia management for emergent cesarean sections in our tertiary care hospital in the first year of pandemic. We searched primarily for the changes in spinal to general anesthesia rate and secondarily for presented adult and neonatal intensive care needs in comparison to the year before the pandemic. We also presented the postoperative PCR tests of the emergent cesarean sections as a tertiary outcome. METHODS: We retrospectively analyzed clinical data such as anesthetic technique, need for postoperative intensive care, duration of hospital stays, postoperative PCR result, and newborn status. RESULTS: The rate of spinal anesthesia changed remarkably from 44.1% to 72.1% after the pandemic (p=0.001). The comparison of the median duration of hospital stays of the pre-pandemic group and post-pandemic group was found significantly longer than that of the before COVID-19 group (p=0.001). The rate of need for postoperative intensive care in the after COVID-19 group was higher (p=0.058). The rate of postoperative intensive care of the newborns in the after COVID-19 group was significantly higher than that of the before COVID-19 group (p=0.001). CONCLUSION: The spinal anesthesia rate for emergent cesarean sections increased significantly during the peak of the COVID-19 pandemic in tertiary care hospitals. Total health care services after the pandemic were enhanced as seen with elevated numbers of hospital stays, postoperative need of adult and neonatal intensive care.


Asunto(s)
Anestesia Raquidea , COVID-19 , Adulto , Recién Nacido , Embarazo , Humanos , Femenino , Cesárea/métodos , Centros de Atención Terciaria , Estudios Retrospectivos , Pandemias , COVID-19/epidemiología , Anestesia Raquidea/métodos
7.
Turk J Anaesthesiol Reanim ; 50(2): 151-154, 2022 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-35544257

RESUMEN

In this study, we report 3 cases of ultrasound-guided rectus sheath block used for anaesthetic management of simple periumbilical surgery. We selected 3 patients based on the American Society of Anaesthesiology I-II and defect sizes known to be smaller than 4 cm without peritoneal involvement. We applied a rectus sheath block with 10 mL of 0.5% bupivacaine and 5 mL of 2% lidocaine bilaterally deposited in the space between rectus abdominis and posterior rectus sheath under real-time ultrasonography. Two of our patients tolerated surgery well with minimal sedoanalgesia; however, one of our patients needed dissociative anaesthesia to be compatible because the surgeon found out that the defect was bigger and adjacent to the peritoneum. Rectus sheath block is an underused technique that has the potential to be used as a sole anaesthetic technique in selected cases. So it would be wise to improve and consider rectus sheath block as a valuable tool when there is no better.

8.
Turk J Anaesthesiol Reanim ; 49(5): 424-427, 2021 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-35110047

RESUMEN

Critical care ultrasound has earned its place not just as a further investigation step but as a bedside physical assessment and monitoring tool. Its potential to become the twenty-first-century stethoscope has proved its accuracy by many protocols so far.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA